Internet of Events
Leaderboard
Traders
Markets
Hot Bets
Surveillance
Pricing
Log in
Get Access
Accrue
/
Home
/
Manifold Markets
/
[Martin Shkreli] Will Galectin Therapeutics ($GALT) stock plummet due to failure of its "NAVIGATE" Phase II/III study?
Manifold
Resolved: YES
BINARY · cpmm-1
[Martin Shkreli] Will Galectin Therapeutics ($GALT) stock plummet due to failure of its "NAVIGATE" Phase II/III study?
Yes
75%
Yes Pool
$580
No Pool
$2K
Resolution
YES